257 results
Page 3 of 13
6-K
EX-99.1
l3du2q7w9gb
1 Aug 22
Current report (foreign)
4:48pm
6-K
EX-2.1
ovlan 0kdmp7tbu
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
6-K
EX-10.3
wbf6i1pl34lgzpas5
8 Jul 22
Current report (foreign)
8:58am
6-K
EX-2.1
ywa07 rd3t
8 Jul 22
Current report (foreign)
8:58am
6-K
EX-10.1
c8zz236fhemkn1qrlgy0
8 Jul 22
Current report (foreign)
8:58am
6-K
EX-10.2
oitiwco72 jtc8skpwf
8 Jul 22
Current report (foreign)
8:58am
20-F/A
dppcwzo
3 Mar 22
Annual report (foreign) (amended)
6:57pm
6-K
EX-99.1
iw9y8x
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.2
ftcoj
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.1
b5ao0zg6cz4kcvyd
25 Feb 22
Portage Biotech Announces Financial Results and Provides Business Update for Third Quarter of 2022 Fiscal Year
12:00am
6-K
EX-99.2
5e2p2o7tq
23 Nov 21
Current report (foreign)
4:30pm
6-K
EX-99.1
6fy 09ia4rypl9
23 Nov 21
Current report (foreign)
4:30pm
6-K
EX-99.1
8b1a sikbd5nj4agb
23 Nov 21
Portage Biotech Announces Financial Results and Provides Business Update for Second Quarter of 2022 Fiscal Year
8:00am
6-K
ktp7yqno fz1ofhln
30 Aug 21
Current report (foreign)
5:21pm
6-K
EX-99.2
ch1hz
30 Aug 21
Current report (foreign)
5:21pm
6-K
EX-99.1
r3nt53p8 hvy
30 Aug 21
Portage Biotech Announces Results for First Quarter of 2022 Fiscal Year
8:00am